REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/13/2026
Back to search
Official data from USPTO
MH MOLECULAR HEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000087048078Class
9, 35, 36, 38, 42, 44
Filing
87048078
Registration
6420058
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
61
Latest update
07/13/2026
Trademark type
Combined
Nice classes
9, 35, 36, 38, 42, 44
Filing date
05/24/2016
Registration date
07/13/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/13/2021
Last transaction
07/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/01/2019
First use in commerce
11/01/2019
Drawing code
3
Owner type
99
Owner location
Heidelberg, DE
Examiner
HISER, CHARLES
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "MOLECULAR" above the word "HEALTH", to the right of"MH", the "MH" being in stylized lettering consisting of elongated vertical shapes.
Holders and representatives
Holders
Molecular Health GmbH
Representatives
Peter T. Wakiyama Troutman Pepper Hamilton Sanders LLP
Technical classification
Nice Classes
Class 9Class 35Class 36Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer databases containing information in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology; downloadable computer databases containing medical and health information or records about or relating to humans; downloadable computer software for accessingorganizingindexingrankingintegratinglinkingreferencingsynthesizinginterpreting and analyzing information from databases in the fields of medicinehealth caregenomicspharmaceuticalslife sciences and biotechnology and databases containing medical and health information or records about or relating to humansincluding biomedical databases containing information about clinicalgenomicmolecularscientific and patient specific datain particular information that clinicians and researchers enable to interpret complex molecular and genomic patient information; downloadable computer databases in the field of biomedical informationin particular links to external reference databasesin particular for the alignment and integration of biomedical information; downloadable computer software and algorithms for storing and sorting biomedical informationin particular links to external reference databasesin particular for the alignment and integration of biomedical informationupdating and expanding global reference data sources across diverse medical disciplines and for allowing the immediate access to biomedical information; downloadable computer databases containing biomedical information in form of human genome sequencesinformation about indication and classifications of diseasesbiomarkersinformation about the molecular mechanism of action of drugstheir targetsmetabolizing enzymesinformation about scientific publications from diverse areas of biomedicine drug-to-drug interactions and the status of drug development; downloadable computer software and algorithms for authorizing or providing access to biomedical databasesin particular application softwareinterface softwaresoftware drivesdata communication softwareinteractive computer software; downloadable computer software and software components for serving domain-specific user demands; downloadable mobile applications for mobile devicessuch as smart phones and tablet computersfor accessingorganizingsynthesizingindexingrankingintegratinglinkingreferencinginterpreting and analyzing information from databases in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology and databases containing medical and health information or records about or relating to humans
Class 35
Business consulting and research services for employers in the field of employee benefits in the nature of offering medical and health care plans to employees and their family members and domestic partners for medical and health care diagnostic and treatment support programs
Class 36
Financial administration of programs and services for payment and reimbursement of employee benefits in the nature of medical and health care diagnostic and treatment support programsfor employees and their family members and domestic partners
Class 38
Providing access to searchable databases containing medicalpharmaceuticalbiologicalclinical and genomic information and medical and health information or recordsmolecular test results and patient specific data about or relating to humans for scientific research purposes; providing access to non-downloadable computer software and algorithms for use by physiciansclinicians and other healthcare professionalslaboratory personnelconsultantsscientists and other researchers for medical diagnostic and treatment and drug safety research and drug or pharmaceuticals or other treatment discoveryresearch and development; providing access to non-downloadable software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment research and drug or pharmaceuticals or other treatment discoveryresearch and development purposes; providing access to non-downloadable computer software and algorithms for use by physiciansclinicians and other healthcare professionalslaboratory personnelconsultantsscientists and other researchers for medical diagnostic and treatment purposes; providing access to software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing access to databases containing medicalpharmaceuticalbiologicalclinicalmolecularsequencing and genomic informationdisease informationbiomarker information and medical or health information or records about or relating to humans and patient specific datamolecular test resultsscientific research for medical diagnostic and treatment purposes
Class 42
Scientific consulting and research services in the fields of health caremedicinelife sciencesbiotechnologypharmaceuticalsbioinformaticsgenomics and pharmaceuticals and pharmaceutical safety for scientific research purposes; Scientific consulting and research services for the retrievalintegrationcorrelationanalysis and interpretation of genomic datasequencing datamolecular datadiseasebiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment research and drug or pharmaceuticals or other treatment discoveryresearch and development purposes; designing and developing and providing temporary use of online searchable databases containing medicalpharmaceuticalbiologicalclinical and genomic information and medical and health information or recordsmolecular test results and patient specific data about or relating to humans for scientific research purposes; designing and developing and providing temporary use of non-downloadable computer software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for use by physiciansclinicians and other healthcare professionalslaboratory personnelconsultantsscientists and other researchers for medical diagnostic and treatment and drug safety research and drug or pharmaceuticals or other treatment discoveryresearch and development; designing and developing and providing temporary use of non-downloadable software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment research and drug or pharmaceuticals or other treatment discoveryresearch and development purposes; software as a Service (SaaS) used in research and consulting for enabling the retrievalintegrationcorrelationanalysis and interpretation of genomic datasequencing data and molecular datadisease informationbiomarker informationdrug protocolsdrug interactionsclinical profilespatient specific datamolecular test resultsdata from clinical studiesscientific research and health and medical informationrecords or data for medicaldiagnostic and treatment and drug safety research and drug or pharmaceuticals or other treatment discoveryresearch and development purposes; provision of non-downloadable mobile applications for mobile devicessuch as smart phones and tabletsnon-downloadable web applications accessible through the Internet for accessing databases in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticals and pharmaceutical safetylife sciences and biotechnology; data collection services for scientific research purposes in the fields of genomicshealth carepharmaceuticalslife sciencesbioinformaticsbiotechnology and medicine; scientific research services for the retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing temporary use of non-downloadable computer software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for use by physiciansclinicians and other healthcare professionalslaboratory personnelconsultantsscientists and other researchers for medical diagnostic and treatment purposes; providing temporary use of non-downloadable software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomic datasequencing data and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing information in the fields of life sciencesbiotechnologybioinformatics
Class 44
Medical consulting services for the retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing online databases containing medicalpharmaceuticalbiologicalclinicalmolecularsequencing and genomic informationdisease informationbiomarker information and medical or health information or records about or relating to humans and patient specific datamolecular test resultsscientific research for medical diagnostic and treatment purposes; medical consulting services in the fields of healthmedical carebiotechnologybioinformaticslife sciencespharmaceuticals and medicine; providing information in the fields of healthhealthcarepharmaceuticals and pharmaceutical safetygenetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing pharmaceutical informationincluding information about drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols
Publications
History of USPTO decisions and trademark events.
61 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/13/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/09/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/25/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/25/2021
ALIE
ASSIGNED TO LIE
05/25/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/22/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2020
GNRT
NON-FINAL ACTION E-MAILED
08/21/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/21/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/31/2020
IUAF
USE AMENDMENT FILED
07/10/2020
EISU
TEAS STATEMENT OF USE RECEIVED
07/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/15/2020
EX5G
SOU EXTENSION 5 GRANTED
01/14/2020
EXT5
SOU EXTENSION 5 FILED
01/09/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/09/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/13/2019
EX4G
SOU EXTENSION 4 GRANTED
07/11/2019
EXT4
SOU EXTENSION 4 FILED
07/11/2019
EEXT
SOU TEAS EXTENSION RECEIVED
07/11/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/15/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/11/2019
EX3G
SOU EXTENSION 3 GRANTED
01/11/2019
EXT3
SOU EXTENSION 3 FILED
01/11/2019
EEXT
SOU TEAS EXTENSION RECEIVED
01/11/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/13/2018
EX2G
SOU EXTENSION 2 GRANTED
07/11/2018
EXT2
SOU EXTENSION 2 FILED
07/11/2018
EEXT
SOU TEAS EXTENSION RECEIVED
07/11/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/11/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/21/2018
EX1G
SOU EXTENSION 1 GRANTED
02/20/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/20/2018
NREV
NOTICE OF REVIVAL - E-MAILED
02/05/2018
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
02/05/2018
PETG
PETITION TO REVIVE-GRANTED
02/05/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
02/05/2018
EXT1
SOU EXTENSION 1 FILED
01/11/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/11/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/16/2017
PUBO
PUBLISHED FOR OPPOSITION
05/16/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/26/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/05/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/27/2017
GNRT
NON-FINAL ACTION E-MAILED
03/27/2017
CNRT
NON-FINAL ACTION WRITTEN
03/27/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2016
GNRT
NON-FINAL ACTION E-MAILED
09/16/2016
CNRT
NON-FINAL ACTION WRITTEN
09/16/2016
DOCK
ASSIGNED TO EXAMINER
09/08/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2016
NWAP
NEW APPLICATION ENTERED
05/27/2016
Continuous trademark protection
Get notified about every new filing that threatens MH MOLECULAR HEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.